Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2003
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003040256A3 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
09/18/2003WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176704 Tinuvin P-Hindred Amine Light Stablizer and derivatives thereof
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176461 Aminopiperidines
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176452 Oral absorption
09/18/2003US20030176444 For therapy of inflammation
09/18/2003US20030176443 Pyridylpyrimidine derivatives as effective compounds against prion diseases
09/18/2003US20030176438 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/18/2003US20030176437 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
09/18/2003US20030176436 For therapy and prophylaxis of bacterial infections, or their use as antiseptics, sterilizants, or disinfectants
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/18/2003US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs
09/18/2003US20030176418 For therapy of Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Down Syndrome, Pick disease, dementia, clinical depression, age- related cognitive decline
09/18/2003US20030176415 1,2,3,4-tetrahydroisoquinoline derivatives
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/18/2003US20030172847 Also transforming crude quinophthalone pigments into a finely divided pigmentary state.
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478958A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478276A1 Azepane derivatives and their use as atk1 inhibitors
09/18/2003CA2478110A1 Novel fluorescent label compounds
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2478028A1 Benzimidazole-derivatives for the treatment of sexual dysfunction
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/18/2003CA2475254A1 Pyridinyloxy derivatives as 5-ht receptor ligands
09/18/2003CA2423259A1 New compounds derived from quinazoline, the process for preparing them, and the pharmaceutical compositions containing them
09/17/2003EP1344789A2 Thermosetting resin composition containing malemide and/or vinyl compounds
09/17/2003EP1344777A1 Imidazole derivatives, process for their preparation and their use
09/17/2003EP1344773A1 Growth hormone secretagogues
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343796A2 Compounds and methods
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343766A1 Cyclization process step in the making of quinolones and naphthyridines
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343530A1 Oral pharmaceutical composition containing a block copolymer
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1343497A1 $g(D)?2 ,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1058548B1 The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003EP0977737B1 Crf antagonistic quino- and quinazolines
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003EP0754682B9 Aminostilbazole derivative and medicine
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443174A Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443068A Combinations of depepotidyl peptidase IV inhibitors and other antidiabetic agents for treatment of diabete mellitus
09/17/2003CN1121403C Quinoxalinediones
09/17/2003CN1121393C Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
09/17/2003CN1121391C Substituted 3-cyano quinolines
09/17/2003CN1121386C Chemical process for reduction of 1-substituted-3-hydroxymethy1-4-(4-fluorophenyl)
09/16/2003US6620945 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents
09/16/2003US6620943 Oxidation of 5-amino-1-(2,6-dichloro-4-trifluoromethylphenyl) -3-cyano-4-trifluoromethylthiopyrazole with trifluoroperacetic acid in the presence of boric acid to form fipronil, used as pesticides
09/16/2003US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/16/2003US6620832 Substituted ureas
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620823 Antiinflammatory agents; rheumatic disorders
09/16/2003US6620815 Oxazolidinones and uses thereof
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2142610C Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 1080